Oregon Public Employees Retirement Fund’s ANI Pharmaceuticals ANIP Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Hold	4,139	–	–	﹤0.01%	1341
2026 Q1	$318K	Buy	4,139 +53	+1%	+$4.14K	﹤0.01%	1318
2025 Q4	$323K	Buy	4,086 +200	+5%	+$17.3K	﹤0.01%	1308
2025 Q3	$356K	Hold	3,886	–	–	﹤0.01%	1260
2025 Q2	$254K	Buy	3,886 +100	+3%	+$6.51K	﹤0.01%	1333
2025 Q1	$253K	Sell	3,786 -100	-3%	-$5.97K	﹤0.01%	1326
2024 Q4	$215K	Hold	3,886	–	–	﹤0.01%	1393
2024 Q3	$232K	Buy	3,886 +200	+5%	+$12.2K	﹤0.01%	1382
2024 Q2	$235K	Sell	3,686 -400	-10%	-$26K	﹤0.01%	1356
2024 Q1	$282K	Sell	4,086 -368	-8%	-$22.2K	0.01%	1335
2023 Q4	$246K	Sell	4,454 -300	-6%	-$16.5K	﹤0.01%	1421
2023 Q3	$276K	Buy	4,754 +400	+9%	+$23.1K	﹤0.01%	1486
2023 Q2	$234K	Buy	4,354 +300	+7%	+$13.3K	﹤0.01%	1550
2023 Q1	$161K	Sell	4,054 -10	-0.2%	-$422	﹤0.01%	1618
2022 Q4	$163K	Buy	4,064 +55	+1%	+$2.07K	﹤0.01%	1618
2022 Q3	$129K	Sell	4,009 -288	-7%	-$9.86K	﹤0.01%	1631
2022 Q2	$127K	Sell	4,297 -481	-10%	-$13.9K	﹤0.01%	1489
2022 Q1	$134K	Buy	4,778 +1,126	+31%	+$42K	﹤0.01%	1665
2021 Q4	$168K	Sell	3,652 -200	-5%	-$8.59K	﹤0.01%	1537
2021 Q3	$126K	Hold	3,852	–	–	﹤0.01%	1554
2021 Q2	$135K	Hold	3,852	–	–	﹤0.01%	1552
2021 Q1	$139K	Buy	3,852 +100	+3%	+$3.13K	﹤0.01%	1564
2020 Q4	$109K	Sell	3,752 -60	-2%	-$1.72K	﹤0.01%	1563
2020 Q3	$108K	Hold	3,812	–	–	﹤0.01%	1510
2020 Q2	$123K	Hold	3,812	–	–	﹤0.01%	1484
2020 Q1	$155K	Hold	3,812	–	–	﹤0.01%	1398
2019 Q4	$235K	Buy	3,812 +400	+12%	+$26.5K	﹤0.01%	1433
2019 Q3	$249K	Buy	3,412 +100	+3%	+$7.48K	﹤0.01%	1475
2019 Q2	$272K	Buy	3,312 +100	+3%	+$7.11K	﹤0.01%	1467
2019 Q1	$227K	Buy	3,212 +58	+2%	+$3.41K	﹤0.01%	1490
2018 Q4	$142K	Buy	+3,154	New	+$165K	﹤0.01%	1574

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oregon Public Employees Retirement Fund's ANIP Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 4,139 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #1341.

Oregon Public Employees Retirement Fund first reported a position in ANIP in Q4 2018 and has held it in 31 quarters since. The position peaked at $356K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Oregon Public Employees Retirement Fund held 4,139 shares of ANI Pharmaceuticals worth $343K as of Q2 2026.
Oregon Public Employees Retirement Fund left its ANI Pharmaceuticals share count unchanged in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1341 holding.
Oregon Public Employees Retirement Fund first reported a position in ANI Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
Oregon Public Employees Retirement Fund's ANI Pharmaceuticals position peaked at $356K in Q3 2025.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.